1. Home
  2. BFC vs NBTX Comparison

BFC vs NBTX Comparison

Compare BFC & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$155.29

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$38.89

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFC
NBTX
Founded
1894
2003
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
BFC
NBTX
Price
$155.29
$38.89
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$157.00
$36.00
AVG Volume (30 Days)
82.1K
114.3K
Earning Date
04-16-2026
03-31-2026
Dividend Yield
1.52%
N/A
EPS Growth
11.23
N/A
EPS
1.78
N/A
Revenue
N/A
N/A
Revenue This Year
$58.67
$58.17
Revenue Next Year
$2.01
N/A
P/E Ratio
$85.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$115.29
$6.90
52 Week High
$154.42
$57.14

Technical Indicators

Market Signals
Indicator
BFC
NBTX
Relative Strength Index (RSI) 64.11 51.61
Support Level $134.81 $38.89
Resistance Level N/A $42.40
Average True Range (ATR) 4.97 2.45
MACD 0.53 -0.05
Stochastic Oscillator 91.09 60.57

Price Performance

Historical Comparison
BFC
NBTX

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: